CAL
TMO icon

Capital Advisors Ltd’s Thermo Fisher Scientific TMO Stock Holding History

Capital Advisors Ltd’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$441K Sell
879
-142
-14% -$68.2K 0.04% 198
2026
Q1 		$502K Buy
1,021
+968
+1,826% +$525K 0.06% 173
2025
Q4 		$5K Sell
53
-970
-95% -$549K ﹤0.01% 953
2025
Q3 		$496K Buy
1,023
+5
+0.5% +$2.33K 0.06% 165
2025
Q2 		$413K Sell
1,018
-193
-16% -$80.7K 0.05% 186
2025
Q1 		$603K Buy
1,211
+2
+0.2% +$1.08K 0.08% 139
2024
Q4 		$629K Sell
1,209
-26
-2% -$14.3K 0.08% 137
2024
Q3 		$764K Buy
1,235
+17
+1% +$10.1K 0.09% 122
2024
Q2 		$674K Buy
1,218
+6
+0.5% +$3.44K 0.09% 128
2024
Q1 		$704K Buy
1,212
+28
+2% +$15.7K 0.09% 124
2023
Q4 		$628K Sell
1,184
-8
-0.7% -$3.87K 0.09% 127
2023
Q3 		$603K Buy
1,192
+42
+4% +$22.4K 0.09% 127
2023
Q2 		$600K Buy
1,150
+309
+37% +$167K 0.09% 131
2023
Q1 		$485K Sell
841
-244
-22% -$138K 0.08% 136
2022
Q4 		$455K Buy
1,085
+265
+32% +$140K 0.08% 145
2022
Q3 		$416K Buy
820
+38
+5% +$21.3K 0.08% 143
2022
Q2 		$425K Buy
782
+68
+10% +$37.4K 0.08% 146
2022
Q1 		$422K Buy
714
+143
+25% +$82.1K 0.07% 154
2021
Q4 		$381K Buy
571
+155
+37% +$96.8K 0.06% 166
2021
Q3 		$238K Buy
416
+336
+420% +$184K 0.04% 191
2021
Q2 		$40K Hold
80
– – 0.01% 329
2021
Q1 		$37K Buy
+80
New +$38.2K 0.01% 316
2020
Q2 		– Sell
-40
Closed -$11K – 478
2020
Q1 		$11K Hold
40
– – ﹤0.01% 359
2019
Q4 		$13K Hold
40
– – ﹤0.01% 335
2019
Q3 		$12K Sell
40
-100
-71% -$28.6K ﹤0.01% 342
2019
Q2 		$41K Buy
140
+100
+250% +$27.5K 0.01% 297
2019
Q1 		$11K Hold
40
– – ﹤0.01% 364
2018
Q4 		$9K Buy
+40
New +$9.38K ﹤0.01% 382

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Capital Advisors Ltd's TMO Position: Q2 2026 in Review

Capital Advisors Ltd reduced its Thermo Fisher Scientific (TMO) stake by 14% in Q2 2026, selling an estimated $68.2K and leaving 879 shares worth $441K. The position accounts for 0.04% of the portfolio, ranked #198.

Capital Advisors Ltd first reported a position in TMO in Q4 2018 and has held it in 28 quarters since. The position peaked at $764K in Q3 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Capital Advisors Ltd held 879 shares of Thermo Fisher Scientific worth $441K as of Q2 2026.
  • Capital Advisors Ltd sold 142 Thermo Fisher Scientific shares in Q2 2026, an estimated $68.2K.
  • Thermo Fisher Scientific made up 0.04% of Capital Advisors Ltd's portfolio in Q2 2026, its #198 holding.
  • Capital Advisors Ltd first reported a position in Thermo Fisher Scientific in Q4 2018 and has held it in 28 quarters since.
  • Capital Advisors Ltd's Thermo Fisher Scientific position peaked at $764K in Q3 2024.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Capital Advisors Ltd's 13F filing for Q2 2026, filed 16 Jul 2026.